Company: HRTX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028374
Chunk: 115

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1B
Chunk 115
---
580
    )
     
    $
    (110,559
    )
     
    $
    (182,024
    )

    Adjustments to reconcile net loss to net cash used in operating activities:

    Stock-based compensation expense

    12,962

    32,854

    42,980

    Depreciation and amortization

    2,492

    2,899

    2,889

    Amortization of debt discount

    751

    133

    —

    Amortization of debt issuance costs

    210

    206

    202

    Accretion of discount on short-term investments

    (2,143
    )

    (1,739
    )

    (736
    )

    Retirement and impairment of property and equipment

    4,409

    617

    209

    (Gain)/Loss on disposal of property and equipment

    (27
    )

    10

    74

    Change in operating assets and liabilities:

    Accounts receivable

    (18,744
    )

    (8,088
    )

    (16,550
    )

    Inventory

    (11,050
    )

    12,463

    (6,191
    )

    Prepaid expenses and other assets

    (9,927
    )

    15,426

    1,010

    Accounts payable

    8,469

    15

    (578
    )

    Accrued clinical and manufacturing liabilities

    3,220

    (2,177
    )

    752

    Accrued payroll and employee liabilities

    330

    (4,192
    )

    (1,847
    )

    Other accrued liabilities

    99

    3,343

    12,898

    Net cash used in operating activities

    (22,529
    )

    (58,789
    )

    (146,912
    )

    Investing activities:

    Purchases of short-term investments

    (103,087
    )

    (87,658
    )

    (145,683
    )

    Maturities and sales of short-term investments

    123,480

    107,185

    143,957

    Purchases of property and equipment

    (1,706